Industry Research Reports

Home > Reports > Service & Software > Global Plasma and Serum Proteomics Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Plasma and Serum Proteomics Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-07-17

Pages: 205 Pages

Report ld: 6977455

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Plasma and Serum Proteomics Analysis Service Market Size(US$)

CAGR 2026-2032

12.0%

Market Size,2032

USD 1,629

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 823 million

Market Forecast in 2032(Value)

US$ 1,629 million

CAGR

12.0%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Plasma and Serum Proteomics Analysis Service market size was US$ 747 million in 2025 and is forecast to reach a readjusted size of US$ 1629 million by 2032 with a CAGR of 12.0% during the forecast period 2026-2032.

Plasma and Serum Proteomics Analysis Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.

As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.

Plasma and Serum Proteomics Analysis Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.

These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.

Plasma and Serum Proteomics Analysis Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.

Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.

The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.

The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.

Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.

Plasma and Serum Proteomics Analysis Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.

As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.

The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.

The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.

Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.

Future demand for Plasma and Serum Proteomics Analysis Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.

Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.

With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.

The global Plasma and Serum Proteomics Analysis Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Plasma Proteomics Analysis Service
Serum Proteomics Analysis Service

Segment by Application

Disease Biomarker Research
Drug Development
Clinical Research
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Plasma and Serum Proteomics Analysis Service value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Plasma Proteomics Analysis Service

1.2.3 Serum Proteomics Analysis Service

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Disease Biomarker Research

1.3.3 Drug Development

1.3.4 Clinical Research

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Plasma and Serum Proteomics Analysis Service Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Region (2021-2026)

2.4 Global Plasma and Serum Proteomics Analysis Service Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

2.5.2 Europe Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

2.5.3 China Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

2.5.4 Japan Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

2.5.5 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

2.5.6 India Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

2.5.7 South America Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

2.5.8 Middle East Plasma and Serum Proteomics Analysis Service Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Plasma and Serum Proteomics Analysis Service Historical Market Size by Type (2021-2026)

3.2 Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Plasma and Serum Proteomics Analysis Service

4 Breakdown Data by Application

4.1 Global Plasma and Serum Proteomics Analysis Service Historical Market Size by Application (2021-2026)

4.2 Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Plasma and Serum Proteomics Analysis Service Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Plasma and Serum Proteomics Analysis Service Players by Revenue (2021-2026)

5.1.2 Global Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Plasma and Serum Proteomics Analysis Service Revenue

5.4 Global Plasma and Serum Proteomics Analysis Service Market Concentration Analysis

5.4.1 Global Plasma and Serum Proteomics Analysis Service Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Plasma and Serum Proteomics Analysis Service Revenue in 2025

5.5 Global Key Players of Plasma and Serum Proteomics Analysis Service Head Offices and Areas Served

5.6 Global Key Players of Plasma and Serum Proteomics Analysis Service, Product and Application

5.7 Global Key Players of Plasma and Serum Proteomics Analysis Service, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)

6.1.2.2 North America Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)

6.1.3.2 North America Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

6.1.4 North America Plasma and Serum Proteomics Analysis Service Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)

6.2.2.2 Europe Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)

6.2.3.2 Europe Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

6.2.4 Europe Plasma and Serum Proteomics Analysis Service Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)

6.3.2.2 China Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)

6.3.3.2 China Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

6.3.4 China Plasma and Serum Proteomics Analysis Service Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)

6.4.2.2 Japan Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)

6.4.3.2 Japan Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

6.4.4 Japan Plasma and Serum Proteomics Analysis Service Major Customers

6.4.5 Japan Market Trends and Opportunities

6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers

6.5.1 Southeast Asia Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)

6.5.2.2 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)

6.5.3.2 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

6.5.4 Southeast Asia Plasma and Serum Proteomics Analysis Service Major Customers

6.5.5 Southeast Asia Market Trends and Opportunities

6.6 India Market: Players, Segments, Downstream and Major Customers

6.6.1 India Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026)

6.6.2 India Market Size by Type

6.6.2.1 India Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)

6.6.2.2 India Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

6.6.3 India Market Size by Application

6.6.3.1 India Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)

6.6.3.2 India Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

6.6.4 India Plasma and Serum Proteomics Analysis Service Major Customers

6.6.5 India Market Trends and Opportunities

7 Key Player Profiles

7.1 Olink (Thermo Fisher Scientific)

7.1.1 Olink (Thermo Fisher Scientific) Company Details

7.1.2 Olink (Thermo Fisher Scientific) Business Overview

7.1.3 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Introduction

7.1.4 Olink (Thermo Fisher Scientific) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.1.5 Olink (Thermo Fisher Scientific) Recent Development

7.2 SomaLogic (Illumina)

7.2.1 SomaLogic (Illumina) Company Details

7.2.2 SomaLogic (Illumina) Business Overview

7.2.3 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Introduction

7.2.4 SomaLogic (Illumina) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.2.5 SomaLogic (Illumina) Recent Development

7.3 Labcorp

7.3.1 Labcorp Company Details

7.3.2 Labcorp Business Overview

7.3.3 Labcorp Plasma and Serum Proteomics Analysis Service Introduction

7.3.4 Labcorp Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.3.5 Labcorp Recent Development

7.4 BostonGene

7.4.1 BostonGene Company Details

7.4.2 BostonGene Business Overview

7.4.3 BostonGene Plasma and Serum Proteomics Analysis Service Introduction

7.4.4 BostonGene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.4.5 BostonGene Recent Development

7.5 CellCarta

7.5.1 CellCarta Company Details

7.5.2 CellCarta Business Overview

7.5.3 CellCarta Plasma and Serum Proteomics Analysis Service Introduction

7.5.4 CellCarta Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.5.5 CellCarta Recent Development

7.6 GENEWIZ (Azenta Life Sciences)

7.6.1 GENEWIZ (Azenta Life Sciences) Company Details

7.6.2 GENEWIZ (Azenta Life Sciences) Business Overview

7.6.3 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Introduction

7.6.4 GENEWIZ (Azenta Life Sciences) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.6.5 GENEWIZ (Azenta Life Sciences) Recent Development

7.7 CDI Labs

7.7.1 CDI Labs Company Details

7.7.2 CDI Labs Business Overview

7.7.3 CDI Labs Plasma and Serum Proteomics Analysis Service Introduction

7.7.4 CDI Labs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.7.5 CDI Labs Recent Development

7.8 Biognosys

7.8.1 Biognosys Company Details

7.8.2 Biognosys Business Overview

7.8.3 Biognosys Plasma and Serum Proteomics Analysis Service Introduction

7.8.4 Biognosys Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.8.5 Biognosys Recent Development

7.9 Discovery Life Sciences

7.9.1 Discovery Life Sciences Company Details

7.9.2 Discovery Life Sciences Business Overview

7.9.3 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Introduction

7.9.4 Discovery Life Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.9.5 Discovery Life Sciences Recent Development

7.10 Firalis Molecular Precision

7.10.1 Firalis Molecular Precision Company Details

7.10.2 Firalis Molecular Precision Business Overview

7.10.3 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Introduction

7.10.4 Firalis Molecular Precision Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.10.5 Firalis Molecular Precision Recent Development

7.11 Cell Signaling Technology (CST)

7.11.1 Cell Signaling Technology (CST) Company Details

7.11.2 Cell Signaling Technology (CST) Business Overview

7.11.3 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Introduction

7.11.4 Cell Signaling Technology (CST) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.11.5 Cell Signaling Technology (CST) Recent Development

7.12 Sampled (Infinity Biologix)

7.12.1 Sampled (Infinity Biologix) Company Details

7.12.2 Sampled (Infinity Biologix) Business Overview

7.12.3 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Introduction

7.12.4 Sampled (Infinity Biologix) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.12.5 Sampled (Infinity Biologix) Recent Development

7.13 APTBIO

7.13.1 APTBIO Company Details

7.13.2 APTBIO Business Overview

7.13.3 APTBIO Plasma and Serum Proteomics Analysis Service Introduction

7.13.4 APTBIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.13.5 APTBIO Recent Development

7.14 Sinotech Genomics

7.14.1 Sinotech Genomics Company Details

7.14.2 Sinotech Genomics Business Overview

7.14.3 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Introduction

7.14.4 Sinotech Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.14.5 Sinotech Genomics Recent Development

7.15 Biodesix

7.15.1 Biodesix Company Details

7.15.2 Biodesix Business Overview

7.15.3 Biodesix Plasma and Serum Proteomics Analysis Service Introduction

7.15.4 Biodesix Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.15.5 Biodesix Recent Development

7.16 Panome Bio

7.16.1 Panome Bio Company Details

7.16.2 Panome Bio Business Overview

7.16.3 Panome Bio Plasma and Serum Proteomics Analysis Service Introduction

7.16.4 Panome Bio Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.16.5 Panome Bio Recent Development

7.17 Novogene

7.17.1 Novogene Company Details

7.17.2 Novogene Business Overview

7.17.3 Novogene Plasma and Serum Proteomics Analysis Service Introduction

7.17.4 Novogene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.17.5 Novogene Recent Development

7.18 PTM BIO

7.18.1 PTM BIO Company Details

7.18.2 PTM BIO Business Overview

7.18.3 PTM BIO Plasma and Serum Proteomics Analysis Service Introduction

7.18.4 PTM BIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.18.5 PTM BIO Recent Development

7.19 BGI Genomics

7.19.1 BGI Genomics Company Details

7.19.2 BGI Genomics Business Overview

7.19.3 BGI Genomics Plasma and Serum Proteomics Analysis Service Introduction

7.19.4 BGI Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.19.5 BGI Genomics Recent Development

7.20 Evotec

7.20.1 Evotec Company Details

7.20.2 Evotec Business Overview

7.20.3 Evotec Plasma and Serum Proteomics Analysis Service Introduction

7.20.4 Evotec Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.20.5 Evotec Recent Development

7.21 Metware Biotechnology

7.21.1 Metware Biotechnology Company Details

7.21.2 Metware Biotechnology Business Overview

7.21.3 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Introduction

7.21.4 Metware Biotechnology Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.21.5 Metware Biotechnology Recent Development

7.22 MRM Proteomics

7.22.1 MRM Proteomics Company Details

7.22.2 MRM Proteomics Business Overview

7.22.3 MRM Proteomics Plasma and Serum Proteomics Analysis Service Introduction

7.22.4 MRM Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.22.5 MRM Proteomics Recent Development

7.23 Lc-Bio Technologies

7.23.1 Lc-Bio Technologies Company Details

7.23.2 Lc-Bio Technologies Business Overview

7.23.3 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Introduction

7.23.4 Lc-Bio Technologies Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.23.5 Lc-Bio Technologies Recent Development

7.24 Eurofins Scientific

7.24.1 Eurofins Scientific Company Details

7.24.2 Eurofins Scientific Business Overview

7.24.3 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Introduction

7.24.4 Eurofins Scientific Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.24.5 Eurofins Scientific Recent Development

7.25 MtoZ-Biolabs

7.25.1 MtoZ-Biolabs Company Details

7.25.2 MtoZ-Biolabs Business Overview

7.25.3 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Introduction

7.25.4 MtoZ-Biolabs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.25.5 MtoZ-Biolabs Recent Development

7.26 Creative Proteomics

7.26.1 Creative Proteomics Company Details

7.26.2 Creative Proteomics Business Overview

7.26.3 Creative Proteomics Plasma and Serum Proteomics Analysis Service Introduction

7.26.4 Creative Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.26.5 Creative Proteomics Recent Development

7.27 Macrogen

7.27.1 Macrogen Company Details

7.27.2 Macrogen Business Overview

7.27.3 Macrogen Plasma and Serum Proteomics Analysis Service Introduction

7.27.4 Macrogen Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.27.5 Macrogen Recent Development

7.28 TATAA Biocenter

7.28.1 TATAA Biocenter Company Details

7.28.2 TATAA Biocenter Business Overview

7.28.3 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Introduction

7.28.4 TATAA Biocenter Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.28.5 TATAA Biocenter Recent Development

7.29 OmicScouts (Momentum Biotechnologies)

7.29.1 OmicScouts (Momentum Biotechnologies) Company Details

7.29.2 OmicScouts (Momentum Biotechnologies) Business Overview

7.29.3 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Introduction

7.29.4 OmicScouts (Momentum Biotechnologies) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.29.5 OmicScouts (Momentum Biotechnologies) Recent Development

7.30 Precision Biomarker Laboratories (PBL)

7.30.1 Precision Biomarker Laboratories (PBL) Company Details

7.30.2 Precision Biomarker Laboratories (PBL) Business Overview

7.30.3 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Introduction

7.30.4 Precision Biomarker Laboratories (PBL) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.30.5 Precision Biomarker Laboratories (PBL) Recent Development

7.31 Shanghai OE Biotech

7.31.1 Shanghai OE Biotech Company Details

7.31.2 Shanghai OE Biotech Business Overview

7.31.3 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Introduction

7.31.4 Shanghai OE Biotech Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.31.5 Shanghai OE Biotech Recent Development

7.32 RxCelerate

7.32.1 RxCelerate Company Details

7.32.2 RxCelerate Business Overview

7.32.3 RxCelerate Plasma and Serum Proteomics Analysis Service Introduction

7.32.4 RxCelerate Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.32.5 RxCelerate Recent Development

7.33 Proteomics International

7.33.1 Proteomics International Company Details

7.33.2 Proteomics International Business Overview

7.33.3 Proteomics International Plasma and Serum Proteomics Analysis Service Introduction

7.33.4 Proteomics International Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.33.5 Proteomics International Recent Development

7.34 Proteome Sciences

7.34.1 Proteome Sciences Company Details

7.34.2 Proteome Sciences Business Overview

7.34.3 Proteome Sciences Plasma and Serum Proteomics Analysis Service Introduction

7.34.4 Proteome Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.34.5 Proteome Sciences Recent Development

7.35 Westlake Omics

7.35.1 Westlake Omics Company Details

7.35.2 Westlake Omics Business Overview

7.35.3 Westlake Omics Plasma and Serum Proteomics Analysis Service Introduction

7.35.4 Westlake Omics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.35.5 Westlake Omics Recent Development

7.36 Crown Bioscience

7.36.1 Crown Bioscience Company Details

7.36.2 Crown Bioscience Business Overview

7.36.3 Crown Bioscience Plasma and Serum Proteomics Analysis Service Introduction

7.36.4 Crown Bioscience Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.36.5 Crown Bioscience Recent Development

7.37 VProteomics

7.37.1 VProteomics Company Details

7.37.2 VProteomics Business Overview

7.37.3 VProteomics Plasma and Serum Proteomics Analysis Service Introduction

7.37.4 VProteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.37.5 VProteomics Recent Development

7.38 Shanghai Majorbio Bio-Pharm

7.38.1 Shanghai Majorbio Bio-Pharm Company Details

7.38.2 Shanghai Majorbio Bio-Pharm Business Overview

7.38.3 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Introduction

7.38.4 Shanghai Majorbio Bio-Pharm Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.38.5 Shanghai Majorbio Bio-Pharm Recent Development

7.39 Applied Biomics

7.39.1 Applied Biomics Company Details

7.39.2 Applied Biomics Business Overview

7.39.3 Applied Biomics Plasma and Serum Proteomics Analysis Service Introduction

7.39.4 Applied Biomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.39.5 Applied Biomics Recent Development

7.40 Sapient Bioanalytics

7.40.1 Sapient Bioanalytics Company Details

7.40.2 Sapient Bioanalytics Business Overview

7.40.3 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Introduction

7.40.4 Sapient Bioanalytics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

7.40.5 Sapient Bioanalytics Recent Development

8 Plasma and Serum Proteomics Analysis Service Market Dynamics

8.1 Plasma and Serum Proteomics Analysis Service Industry Trends

8.2 Plasma and Serum Proteomics Analysis Service Market Drivers

8.3 Plasma and Serum Proteomics Analysis Service Market Challenges

8.4 Plasma and Serum Proteomics Analysis Service Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Plasma and Serum Proteomics Analysis Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Plasma and Serum Proteomics Analysis Service Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Plasma and Serum Proteomics Analysis Service Revenue Share by Region (2021-2026)

Table 6. Global Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Plasma and Serum Proteomics Analysis Service Revenue Share Forecast by Region (2027-2032)

Table 8. Global Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Type (2021-2026)

Table 10. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Application (2021-2026)

Table 15. Global Plasma and Serum Proteomics Analysis Service Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Plasma and Serum Proteomics Analysis Service Applications

Table 18. Global Plasma and Serum Proteomics Analysis Service Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Plasma and Serum Proteomics Analysis Service Market Share by Players (2021-2026)

Table 20. Global Top Plasma and Serum Proteomics Analysis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma and Serum Proteomics Analysis Service as of 2025)

Table 21. Ranking of Global Top Plasma and Serum Proteomics Analysis Service Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Plasma and Serum Proteomics Analysis Service Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Plasma and Serum Proteomics Analysis Service, Headquarters and Area Served

Table 24. Global Key Players of Plasma and Serum Proteomics Analysis Service, Product and Application

Table 25. Global Key Players of Plasma and Serum Proteomics Analysis Service, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Company (2021-2026)

Table 29. North America Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)

Table 35. China Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026) & (US$ Million)

Table 36. China Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Company (2021-2026)

Table 37. China Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)

Table 38. China Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Company (2021-2026)

Table 41. Japan Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)

Table 43. Southeast Asia Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026) & (US$ Million)

Table 44. Southeast Asia Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Company (2021-2026)

Table 45. Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)

Table 46. Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)

Table 47. India Plasma and Serum Proteomics Analysis Service Revenue by Company (2021-2026) & (US$ Million)

Table 48. India Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Company (2021-2026)

Table 49. India Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026) & (US$ Million)

Table 50. India Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (US$ Million)

Table 51. Olink (Thermo Fisher Scientific) Company Details

Table 52. Olink (Thermo Fisher Scientific) Business Overview

Table 53. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product

Table 54. Olink (Thermo Fisher Scientific) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 55. Olink (Thermo Fisher Scientific) Recent Development

Table 56. SomaLogic (Illumina) Company Details

Table 57. SomaLogic (Illumina) Business Overview

Table 58. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product

Table 59. SomaLogic (Illumina) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 60. SomaLogic (Illumina) Recent Development

Table 61. Labcorp Company Details

Table 62. Labcorp Business Overview

Table 63. Labcorp Plasma and Serum Proteomics Analysis Service Product

Table 64. Labcorp Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 65. Labcorp Recent Development

Table 66. BostonGene Company Details

Table 67. BostonGene Business Overview

Table 68. BostonGene Plasma and Serum Proteomics Analysis Service Product

Table 69. BostonGene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 70. BostonGene Recent Development

Table 71. CellCarta Company Details

Table 72. CellCarta Business Overview

Table 73. CellCarta Plasma and Serum Proteomics Analysis Service Product

Table 74. CellCarta Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 75. CellCarta Recent Development

Table 76. GENEWIZ (Azenta Life Sciences) Company Details

Table 77. GENEWIZ (Azenta Life Sciences) Business Overview

Table 78. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product

Table 79. GENEWIZ (Azenta Life Sciences) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 80. GENEWIZ (Azenta Life Sciences) Recent Development

Table 81. CDI Labs Company Details

Table 82. CDI Labs Business Overview

Table 83. CDI Labs Plasma and Serum Proteomics Analysis Service Product

Table 84. CDI Labs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 85. CDI Labs Recent Development

Table 86. Biognosys Company Details

Table 87. Biognosys Business Overview

Table 88. Biognosys Plasma and Serum Proteomics Analysis Service Product

Table 89. Biognosys Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 90. Biognosys Recent Development

Table 91. Discovery Life Sciences Company Details

Table 92. Discovery Life Sciences Business Overview

Table 93. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product

Table 94. Discovery Life Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 95. Discovery Life Sciences Recent Development

Table 96. Firalis Molecular Precision Company Details

Table 97. Firalis Molecular Precision Business Overview

Table 98. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product

Table 99. Firalis Molecular Precision Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 100. Firalis Molecular Precision Recent Development

Table 101. Cell Signaling Technology (CST) Company Details

Table 102. Cell Signaling Technology (CST) Business Overview

Table 103. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product

Table 104. Cell Signaling Technology (CST) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 105. Cell Signaling Technology (CST) Recent Development

Table 106. Sampled (Infinity Biologix) Company Details

Table 107. Sampled (Infinity Biologix) Business Overview

Table 108. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product

Table 109. Sampled (Infinity Biologix) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 110. Sampled (Infinity Biologix) Recent Development

Table 111. APTBIO Company Details

Table 112. APTBIO Business Overview

Table 113. APTBIO Plasma and Serum Proteomics Analysis Service Product

Table 114. APTBIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 115. APTBIO Recent Development

Table 116. Sinotech Genomics Company Details

Table 117. Sinotech Genomics Business Overview

Table 118. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product

Table 119. Sinotech Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 120. Sinotech Genomics Recent Development

Table 121. Biodesix Company Details

Table 122. Biodesix Business Overview

Table 123. Biodesix Plasma and Serum Proteomics Analysis Service Product

Table 124. Biodesix Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 125. Biodesix Recent Development

Table 126. Panome Bio Company Details

Table 127. Panome Bio Business Overview

Table 128. Panome Bio Plasma and Serum Proteomics Analysis Service Product

Table 129. Panome Bio Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 130. Panome Bio Recent Development

Table 131. Novogene Company Details

Table 132. Novogene Business Overview

Table 133. Novogene Plasma and Serum Proteomics Analysis Service Product

Table 134. Novogene Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 135. Novogene Recent Development

Table 136. PTM BIO Company Details

Table 137. PTM BIO Business Overview

Table 138. PTM BIO Plasma and Serum Proteomics Analysis Service Product

Table 139. PTM BIO Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 140. PTM BIO Recent Development

Table 141. BGI Genomics Company Details

Table 142. BGI Genomics Business Overview

Table 143. BGI Genomics Plasma and Serum Proteomics Analysis Service Product

Table 144. BGI Genomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 145. BGI Genomics Recent Development

Table 146. Evotec Company Details

Table 147. Evotec Business Overview

Table 148. Evotec Plasma and Serum Proteomics Analysis Service Product

Table 149. Evotec Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 150. Evotec Recent Development

Table 151. Metware Biotechnology Company Details

Table 152. Metware Biotechnology Business Overview

Table 153. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product

Table 154. Metware Biotechnology Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 155. Metware Biotechnology Recent Development

Table 156. MRM Proteomics Company Details

Table 157. MRM Proteomics Business Overview

Table 158. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product

Table 159. MRM Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 160. MRM Proteomics Recent Development

Table 161. Lc-Bio Technologies Company Details

Table 162. Lc-Bio Technologies Business Overview

Table 163. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product

Table 164. Lc-Bio Technologies Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 165. Lc-Bio Technologies Recent Development

Table 166. Eurofins Scientific Company Details

Table 167. Eurofins Scientific Business Overview

Table 168. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product

Table 169. Eurofins Scientific Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 170. Eurofins Scientific Recent Development

Table 171. MtoZ-Biolabs Company Details

Table 172. MtoZ-Biolabs Business Overview

Table 173. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product

Table 174. MtoZ-Biolabs Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 175. MtoZ-Biolabs Recent Development

Table 176. Creative Proteomics Company Details

Table 177. Creative Proteomics Business Overview

Table 178. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product

Table 179. Creative Proteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 180. Creative Proteomics Recent Development

Table 181. Macrogen Company Details

Table 182. Macrogen Business Overview

Table 183. Macrogen Plasma and Serum Proteomics Analysis Service Product

Table 184. Macrogen Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 185. Macrogen Recent Development

Table 186. TATAA Biocenter Company Details

Table 187. TATAA Biocenter Business Overview

Table 188. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product

Table 189. TATAA Biocenter Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 190. TATAA Biocenter Recent Development

Table 191. OmicScouts (Momentum Biotechnologies) Company Details

Table 192. OmicScouts (Momentum Biotechnologies) Business Overview

Table 193. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product

Table 194. OmicScouts (Momentum Biotechnologies) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 195. OmicScouts (Momentum Biotechnologies) Recent Development

Table 196. Precision Biomarker Laboratories (PBL) Company Details

Table 197. Precision Biomarker Laboratories (PBL) Business Overview

Table 198. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product

Table 199. Precision Biomarker Laboratories (PBL) Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 200. Precision Biomarker Laboratories (PBL) Recent Development

Table 201. Shanghai OE Biotech Company Details

Table 202. Shanghai OE Biotech Business Overview

Table 203. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product

Table 204. Shanghai OE Biotech Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 205. Shanghai OE Biotech Recent Development

Table 206. RxCelerate Company Details

Table 207. RxCelerate Business Overview

Table 208. RxCelerate Plasma and Serum Proteomics Analysis Service Product

Table 209. RxCelerate Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 210. RxCelerate Recent Development

Table 211. Proteomics International Company Details

Table 212. Proteomics International Business Overview

Table 213. Proteomics International Plasma and Serum Proteomics Analysis Service Product

Table 214. Proteomics International Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 215. Proteomics International Recent Development

Table 216. Proteome Sciences Company Details

Table 217. Proteome Sciences Business Overview

Table 218. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product

Table 219. Proteome Sciences Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 220. Proteome Sciences Recent Development

Table 221. Westlake Omics Company Details

Table 222. Westlake Omics Business Overview

Table 223. Westlake Omics Plasma and Serum Proteomics Analysis Service Product

Table 224. Westlake Omics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 225. Westlake Omics Recent Development

Table 226. Crown Bioscience Company Details

Table 227. Crown Bioscience Business Overview

Table 228. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product

Table 229. Crown Bioscience Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 230. Crown Bioscience Recent Development

Table 231. VProteomics Company Details

Table 232. VProteomics Business Overview

Table 233. VProteomics Plasma and Serum Proteomics Analysis Service Product

Table 234. VProteomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 235. VProteomics Recent Development

Table 236. Shanghai Majorbio Bio-Pharm Company Details

Table 237. Shanghai Majorbio Bio-Pharm Business Overview

Table 238. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product

Table 239. Shanghai Majorbio Bio-Pharm Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 240. Shanghai Majorbio Bio-Pharm Recent Development

Table 241. Applied Biomics Company Details

Table 242. Applied Biomics Business Overview

Table 243. Applied Biomics Plasma and Serum Proteomics Analysis Service Product

Table 244. Applied Biomics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 245. Applied Biomics Recent Development

Table 246. Sapient Bioanalytics Company Details

Table 247. Sapient Bioanalytics Business Overview

Table 248. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product

Table 249. Sapient Bioanalytics Revenue in Plasma and Serum Proteomics Analysis Service Business (2021-2026) & (US$ Million)

Table 250. Sapient Bioanalytics Recent Development

Table 251. Plasma and Serum Proteomics Analysis Service Market Trends

Table 252. Plasma and Serum Proteomics Analysis Service Market Drivers

Table 253. Plasma and Serum Proteomics Analysis Service Market Challenges

Table 254. Plasma and Serum Proteomics Analysis Service Market Restraints

Table 255. Research Programs/Design for This Report

Table 256. Key Data Information from Secondary Sources

Table 257. Key Data Information from Primary Sources

List of Figures

Figure 1. Plasma and Serum Proteomics Analysis Service Product Picture

Figure 2. Global Plasma and Serum Proteomics Analysis Service Market Share by Type: 2025 vs 2032

Figure 3. Plasma Proteomics Analysis Service Features

Figure 4. Serum Proteomics Analysis Service Features

Figure 5. Global Plasma and Serum Proteomics Analysis Service Market Share by Application: 2025 vs 2032

Figure 6. Disease Biomarker Research

Figure 7. Drug Development

Figure 8. Clinical Research

Figure 9. Others

Figure 10. Plasma and Serum Proteomics Analysis Service Report Years Considered

Figure 11. Global Plasma and Serum Proteomics Analysis Service Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 12. Global Plasma and Serum Proteomics Analysis Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Plasma and Serum Proteomics Analysis Service Market Share by Revenue, by Region: 2021 vs 2025

Figure 14. North America Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 15. Europe Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 16. China Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 17. Japan Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. Southeast Asia Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 19. India Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 20. South America Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. Middle East Plasma and Serum Proteomics Analysis Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 22. Global Plasma and Serum Proteomics Analysis Service Market Share by Players in 2025

Figure 23. Global Top Plasma and Serum Proteomics Analysis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma and Serum Proteomics Analysis Service as of 2025)

Figure 24. The Top 10 and 5 Players Market Share by Plasma and Serum Proteomics Analysis Service Revenue in 2025

Figure 25. North America Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

Figure 26. North America Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

Figure 27. Europe Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

Figure 28. Europe Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

Figure 29. China Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

Figure 30. China Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

Figure 31. Japan Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

Figure 32. Japan Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

Figure 33. Southeast Asia Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

Figure 34. Southeast Asia Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

Figure 35. India Plasma and Serum Proteomics Analysis Service Market Share by Type (2021-2026)

Figure 36. India Plasma and Serum Proteomics Analysis Service Market Share by Application (2021-2026)

Figure 37. Olink (Thermo Fisher Scientific) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 38. SomaLogic (Illumina) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 39. Labcorp Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 40. BostonGene Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 41. CellCarta Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 42. GENEWIZ (Azenta Life Sciences) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 43. CDI Labs Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 44. Biognosys Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 45. Discovery Life Sciences Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 46. Firalis Molecular Precision Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 47. Cell Signaling Technology (CST) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 48. Sampled (Infinity Biologix) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 49. APTBIO Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 50. Sinotech Genomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 51. Biodesix Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 52. Panome Bio Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 53. Novogene Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 54. PTM BIO Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 55. BGI Genomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 56. Evotec Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 57. Metware Biotechnology Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 58. MRM Proteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 59. Lc-Bio Technologies Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 60. Eurofins Scientific Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 61. MtoZ-Biolabs Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 62. Creative Proteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 63. Macrogen Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 64. TATAA Biocenter Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 65. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 66. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 67. Shanghai OE Biotech Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 68. RxCelerate Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 69. Proteomics International Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 70. Proteome Sciences Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 71. Westlake Omics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 72. Crown Bioscience Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 73. VProteomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 74. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 75. Applied Biomics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 76. Sapient Bioanalytics Revenue Growth Rate in Plasma and Serum Proteomics Analysis Service Business (2021-2026)

Figure 77. Bottom-up and Top-down Approaches for This Report

Figure 78. Data Triangulation

Figure 79. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Plasma and Serum Proteomics Analysis Service in 2026? zhanKai

The global market size of Plasma and Serum Proteomics Analysis Service in 2026 was 823 Million USD.

What was the global market size of Plasma and Serum Proteomics Analysis Service in 2032? shouQi

What is the annual compound growth rate of the global Plasma and Serum Proteomics Analysis Service market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Plasma and Serum Proteomics Analysis Service market? shouQi

Related Reports

Global Plasma and Serum Proteomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Plasma and Serum Proteomics Analysis Service market is projected to grow from US$ 747 million in 2025 to US$ 1629 million by 2032, at a CAGR of 12.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 199
USD 4900.00
(Single User License)
Plasma and Serum Proteomics Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Plasma and Serum Proteomics Analysis Service was estimated to be worth US$ 747 million in 2025 and is projected to reach US$ 1629 million, growing at a CAGR of 12.0% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 187
USD 3950.00
(Single User License)
Global Plasma and Serum Proteomics Analysis Service Market Research Report 2026
The global Plasma and Serum Proteomics Analysis Service market was valued at US$ 747 million in 2025 and is anticipated to reach US$ 1629 million by 2032, at a CAGR of 12.0% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 201
USD 2900.00
(Single User License)

Global Plasma and Serum Proteomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Plasma and Serum Proteomics Analysis Service market is projected to grow from US$ 747 million in 2025 to US$ 1629 million by 2032, at a CAGR of 12.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 199
USD 4900.00 (Single User License)
Plasma and Serum Proteomics Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Plasma and Serum Proteomics Analysis Service was estimated to be worth US$ 747 million in 2025 and is projected to reach US$ 1629 million, growing at a CAGR of 12.0% from 2026 to 2032.
Published: 2026-07-17
Pages: 187
USD 3950.00 (Single User License)
Global Plasma and Serum Proteomics Analysis Service Market Research Report 2026
The global Plasma and Serum Proteomics Analysis Service market was valued at US$ 747 million in 2025 and is anticipated to reach US$ 1629 million by 2032, at a CAGR of 12.0% from 2026 to 2032.
Published: 2026-07-17
Pages: 201
USD 2900.00 (Single User License)